- Bausch + Lomb Corp.
Bausch + Lomb Corp.
520 Applewood Crescent
Website
Offer Price
Offer Size
3-Year Outlook
Volatility
1st Day Turnover
$18.00
35,000,000
Positive
High
42.84%
Offering Team
Deal Managers
- Morgan Stanley
- Goldman Sachs
- Citigroup
Lawyers
- Davis Polk & Wardwell LLP
Auditors
- PricewaterhouseCoopers LLP
Pre-IPO Investors
Investors
- Google Ventures
- Intel Ventures
- Patricoff Ventures
- Kleiner Perkins
Pre-IPO Holdings(%)
- 30
- 20
- 05
- 18
Deal Highlights
Bausch + Lomb is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world—from the moment of birth through every phase of life. Our mission is simple, yet powerful: helping you see better, to live better. Our comprehensive portfolio of over 400 products is fully integrated and built to serve our customers across the full spectrum of their eye health needs throughout their lives. Our iconic brand i More
Deal Tracker
Investors
Filing
28 Apr, 2022Offer
06 May, 2022Look Ahead
Lock Up Expiry
06 Nov, 2022Earning
Nov 1, 2018IPO Terms
Offer Price | $18.00 |
Offer Size | 35M |